Mikael S. Thomsen - Concepedia

Author

Mikael S. Thomsen

Also Known As

M. S. Thomsen, M.S. Thomsen, M. S. Thomsen, Mikael S Thomsen, Mikael S. Thomsen, Mikael Søndergård Thomsen, Mikael Thomsen

Publications

969

Citations

H-Index

Concepts

All Affiliations

Novo Nordisk (Denmark)University of Copenhagen Novartis (Switzerland)

About

Mikael S. Thomsen is an author at Novo Nordisk (Denmark) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	548
2	Health Sciences	2	2	120
3	Natural Sciences	2	2	45
4	Public Health	2	2	42
5	Engineering	1	1	35

Mikael S. Thomsen

Publications

876

Citations

H-Index

Page 1

	Year	Citations
CYP2C8 and CYP3A4 are the principal enzymes involved in the human <i>in vitro</i> biotransformation of the insulin secretagogue repaglinide Tanja Busk Bidstrup, Inga Bjørnsdottir, Ulla G. Sidelmann, British Journal of Clinical Pharmacology	2003	203
Influence of Drugs Interacting with CYP3A4 on the Pharmacokinetics, Pharmacodynamics, and Safety of the Prandial Glucose Regulator Repaglinide Vibeke Hatorp, Kristian T. Hansen, Mikael S. Thomsen The Journal of Clinical Pharmacology Healthy SubjectsPharmacotherapyInsulin SignalingMetabolic SyndromePharmacological Study	2003	106
Clinical Pharmacokinetics of Artemether and Lumefantrine (Riamet??) Gilbert Lef vre, Mikael S. Thomsen Clinical Drug Investigation Pharmacological StudyPharmacologyClinical PharmacokineticsMedicinePharmacokinetics	1999	97
Pharmacokinetic interaction trial between co-artemether and mefloquine Gilbert Lefèvre, M. Bindschedler, Farkad Ezzet, European Journal of Pharmaceutical Sciences MedicinePharmacotherapyPharmacokinetic Interaction TrialPharmacologyPharmacokinetics	2000	67
Cytochrome P4502E1 Inhibition by Propylene Glycol Prevents Acetaminophen (Paracetamol) Hepatotoxicity in Mice without Cytochrome P4501A2 Inhibition Mikael S. Thomsen, Steffen Loft, Dean W. Roberts, Pharmacology & Toxicology PharmacotherapyExperimental PharmacologyToxicological MechanismOxidative StressToxicology	1995	50
Benzene-induced genotoxicity in mice in vivo detected by the alkaline comet assay: reduction by CYP2E1 inhibition Jingsheng Tuo, Steffen Loft, Mikael S. Thomsen, Mutation Research/Genetic Toxicology BiochemistryMedicineBenzene-induced GenotoxicityToxicologyToxicological Aspect	1996	47
Cardiac effects of co-artemether (artemether/lumefantrine) and mefloquine given alone or in combination to healthy volunteers M. Bindschedler, Gilbert Lefèvre, Farkad Ezzet, European Journal of Clinical Pharmacology Heart FailureCardiovascular DiseaseCardiac EffectsHealthy VolunteersCardiovascular Pharmacology	2000	40
Microfluidic Reactor for Continuous Flow Biotransformations with Immobilized Enzymes: the Example of Lactose Hydrolysis by a Hyperthermophilic β_cont;‐Glycoside Hydrolase Mikael S. Thomsen, Bernd Nidetzky Engineering in Life Sciences Immobilization ProtocolEngineeringBiochemistryMicrofabricationNatural Sciences	2008	35
Pharmacokinetics and Safety of FFR‐rFVIIa after Single Doses in Healthy Subjects Elisabeth Erhardtsen, Povl Nilsson, Marie Johannessen, The Journal of Clinical Pharmacology	2001	28
Evaluation of the Cohort Size in Phase I Dose Escalation Trials Based on Laboratory Data Camilla Buöen, Sture Holm, Mikael S. Thomsen The Journal of Clinical Pharmacology Escalation TrialRetrospective Cohort StudyEpidemiologyCohort SizesDose Escalation Trials	2003	28

Page 1